nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—NR3C1—rheumatoid arthritis	0.238	1	CbGaD
Cyproterone acetate—AR—Ergocalciferol—rheumatoid arthritis	0.105	0.27	CbGbCtD
Cyproterone acetate—Megestrol acetate—Hydrocortisone—rheumatoid arthritis	0.0853	0.366	CrCrCtD
Cyproterone acetate—Medroxyprogesterone Acetate—Hydrocortisone—rheumatoid arthritis	0.0759	0.326	CrCrCtD
Cyproterone acetate—Medroxyprogesterone Acetate—Methylprednisolone—rheumatoid arthritis	0.0716	0.308	CrCrCtD
Cyproterone acetate—NR3C1—Methylprednisolone—rheumatoid arthritis	0.0494	0.126	CbGbCtD
Cyproterone acetate—NR3C1—Triamcinolone—rheumatoid arthritis	0.0375	0.0959	CbGbCtD
Cyproterone acetate—CYP19A1—Betamethasone—rheumatoid arthritis	0.0354	0.0906	CbGbCtD
Cyproterone acetate—NR3C1—Betamethasone—rheumatoid arthritis	0.0321	0.0823	CbGbCtD
Cyproterone acetate—NR3C1—Prednisolone—rheumatoid arthritis	0.0317	0.0812	CbGbCtD
Cyproterone acetate—NR3C1—Hydrocortisone—rheumatoid arthritis	0.0301	0.0769	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—rheumatoid arthritis	0.0299	0.0766	CbGbCtD
Cyproterone acetate—CYP19A1—Dexamethasone—rheumatoid arthritis	0.0206	0.0527	CbGbCtD
Cyproterone acetate—NR3C1—Dexamethasone—rheumatoid arthritis	0.0187	0.0478	CbGbCtD
Cyproterone acetate—AR—duct of salivary gland—rheumatoid arthritis	0.0145	0.751	CbGeAlD
Cyproterone acetate—CYP19A1—connective tissue—rheumatoid arthritis	0.000669	0.0345	CbGeAlD
Cyproterone acetate—CYP19A1—FSH signaling pathway—GRK6—rheumatoid arthritis	0.000651	0.0401	CbGpPWpGaD
Cyproterone acetate—AR—connective tissue—rheumatoid arthritis	0.000593	0.0306	CbGeAlD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—RCAN1—rheumatoid arthritis	0.000531	0.0327	CbGpPWpGaD
Cyproterone acetate—NR3C1—parotid gland—rheumatoid arthritis	0.000488	0.0252	CbGeAlD
Cyproterone acetate—AR—FOXA1 transcription factor network—SFTPD—rheumatoid arthritis	0.000476	0.0293	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—rheumatoid arthritis	0.000472	0.029	CbGpPWpGaD
Cyproterone acetate—NR3C1—saliva-secreting gland—rheumatoid arthritis	0.000467	0.0241	CbGeAlD
Cyproterone acetate—AR—lymphoid tissue—rheumatoid arthritis	0.000433	0.0224	CbGeAlD
Cyproterone acetate—NR3C1—connective tissue—rheumatoid arthritis	0.000429	0.0221	CbGeAlD
Cyproterone acetate—AR—digestive system—rheumatoid arthritis	0.000428	0.0221	CbGeAlD
Cyproterone acetate—AR—tendon—rheumatoid arthritis	0.000407	0.021	CbGeAlD
Cyproterone acetate—Megestrol acetate—NR3C1—rheumatoid arthritis	0.000363	0.632	CrCbGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—RBPJ—rheumatoid arthritis	0.000354	0.0218	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—FKBP5—rheumatoid arthritis	0.000341	0.021	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—MED1—rheumatoid arthritis	0.000315	0.0194	CbGpPWpGaD
Cyproterone acetate—NR3C1—lymphoid tissue—rheumatoid arthritis	0.000314	0.0162	CbGeAlD
Cyproterone acetate—NR3C1—digestive system—rheumatoid arthritis	0.00031	0.016	CbGeAlD
Cyproterone acetate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—MED1—rheumatoid arthritis	0.000309	0.019	CbGpPWpGaD
Cyproterone acetate—NR3C1—tendon—rheumatoid arthritis	0.000295	0.0152	CbGeAlD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—MED1—rheumatoid arthritis	0.000273	0.0168	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—rheumatoid arthritis	0.000265	0.0163	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—EOMES—rheumatoid arthritis	0.000255	0.0157	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—MED1—rheumatoid arthritis	0.000239	0.0147	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—RUNX1—rheumatoid arthritis	0.000238	0.0147	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—BGLAP—rheumatoid arthritis	0.000233	0.0143	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—REL—rheumatoid arthritis	0.000228	0.014	CbGpPWpGaD
Cyproterone acetate—NR3C1—Circadian Clock—MED1—rheumatoid arthritis	0.000225	0.0139	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—rheumatoid arthritis	0.000211	0.368	CrCbGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—PTK2—rheumatoid arthritis	0.000205	0.0126	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—rheumatoid arthritis	0.000181	0.0111	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—VDR—rheumatoid arthritis	0.000175	0.0108	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—REL—rheumatoid arthritis	0.000173	0.0107	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—VDR—rheumatoid arthritis	0.000173	0.0106	CbGpPWpGaD
Cyproterone acetate—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—rheumatoid arthritis	0.000169	0.0104	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—LEP—rheumatoid arthritis	0.000165	0.0101	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—RETN—rheumatoid arthritis	0.000163	0.0101	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDK6—rheumatoid arthritis	0.00016	0.00982	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—NR3C1—rheumatoid arthritis	0.000158	0.0097	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Endogenous sterols—POMC—rheumatoid arthritis	0.000155	0.00953	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ZNF184—rheumatoid arthritis	0.00015	0.00921	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—NFATC1—rheumatoid arthritis	0.000141	0.00867	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—VDR—rheumatoid arthritis	0.000138	0.00852	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—GATA3—rheumatoid arthritis	0.000134	0.00826	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—CAT—rheumatoid arthritis	0.000133	0.0082	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—VDR—rheumatoid arthritis	0.000133	0.00818	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—ETS1—rheumatoid arthritis	0.000128	0.00785	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—SELE—rheumatoid arthritis	0.000126	0.00776	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—NR3C1—rheumatoid arthritis	0.000125	0.00767	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—rheumatoid arthritis	0.000124	0.00764	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—NR3C1—rheumatoid arthritis	0.000121	0.00744	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—MIF—rheumatoid arthritis	0.000119	0.00733	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—rheumatoid arthritis	0.000116	0.00714	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ZNF184—rheumatoid arthritis	0.000114	0.00699	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—rheumatoid arthritis	0.000113	0.00696	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TIMP1—rheumatoid arthritis	0.000108	0.00668	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—VDR—rheumatoid arthritis	0.000105	0.00646	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—HSPD1—rheumatoid arthritis	0.000105	0.00645	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AHR—rheumatoid arthritis	0.000105	0.00644	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—rheumatoid arthritis	0.000102	0.00627	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—GATA3—rheumatoid arthritis	0.000101	0.0062	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—rheumatoid arthritis	9.63e-05	0.00593	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—STAT1—rheumatoid arthritis	9.6e-05	0.00591	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—rheumatoid arthritis	9.56e-05	0.00589	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—rheumatoid arthritis	9.3e-05	0.00572	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AHR—rheumatoid arthritis	9e-05	0.00554	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—AHR—rheumatoid arthritis	8.95e-05	0.00551	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—PTK2—rheumatoid arthritis	8.83e-05	0.00544	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—rheumatoid arthritis	8.6e-05	0.0053	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—STAT1—rheumatoid arthritis	8.26e-05	0.00509	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	8.2e-05	0.00505	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CD4—rheumatoid arthritis	8.16e-05	0.00503	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—HSPD1—rheumatoid arthritis	7.95e-05	0.00489	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—GATA3—rheumatoid arthritis	7.94e-05	0.00489	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—rheumatoid arthritis	7.93e-05	0.00488	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CSF2—rheumatoid arthritis	7.84e-05	0.00483	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL4—rheumatoid arthritis	7.71e-05	0.00475	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1RN—rheumatoid arthritis	7.69e-05	0.00474	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—rheumatoid arthritis	7.62e-05	0.00469	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—rheumatoid arthritis	7.41e-05	0.00456	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—rheumatoid arthritis	7.25e-05	0.00446	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ZNF184—rheumatoid arthritis	7.2e-05	0.00443	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—rheumatoid arthritis	7.19e-05	0.00443	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—rheumatoid arthritis	7.05e-05	0.00434	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HLA-A—rheumatoid arthritis	6.99e-05	0.0043	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—GATA3—rheumatoid arthritis	6.97e-05	0.00429	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—rheumatoid arthritis	6.91e-05	0.00425	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL4—rheumatoid arthritis	6.8e-05	0.00418	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP1—rheumatoid arthritis	6.74e-05	0.00415	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—STAT1—rheumatoid arthritis	6.68e-05	0.00411	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—ADIPOQ—rheumatoid arthritis	6.4e-05	0.00394	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—MAPK8—rheumatoid arthritis	6.28e-05	0.00387	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—rheumatoid arthritis	6.18e-05	0.0038	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—rheumatoid arthritis	6.15e-05	0.00378	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	6.11e-05	0.00376	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—GATA3—rheumatoid arthritis	6.02e-05	0.00371	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MMP1—rheumatoid arthritis	5.94e-05	0.00366	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1RN—rheumatoid arthritis	5.84e-05	0.00359	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	5.83e-05	0.00359	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—STAT1—rheumatoid arthritis	5.75e-05	0.00354	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—RBPJ—rheumatoid arthritis	5.73e-05	0.00353	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—STAT1—rheumatoid arthritis	5.72e-05	0.00352	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	5.54e-05	0.00341	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1A—rheumatoid arthritis	5.54e-05	0.00341	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—rheumatoid arthritis	5.5e-05	0.00339	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCL2—rheumatoid arthritis	5.48e-05	0.00338	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	5.47e-05	0.00337	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ZNF184—rheumatoid arthritis	5.47e-05	0.00336	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MED1—rheumatoid arthritis	5.45e-05	0.00335	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—rheumatoid arthritis	5.4e-05	0.00332	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—rheumatoid arthritis	5.14e-05	0.00316	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NR3C1—rheumatoid arthritis	5.09e-05	0.00314	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Hydrocortisone—rheumatoid arthritis	5.03e-05	0.00049	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Dexamethasone—rheumatoid arthritis	5.03e-05	0.00049	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Betamethasone—rheumatoid arthritis	5.03e-05	0.00049	CcSEcCtD
Cyproterone acetate—Discomfort—Triamcinolone—rheumatoid arthritis	5.02e-05	0.00049	CcSEcCtD
Cyproterone acetate—Fatigue—Cyclosporine—rheumatoid arthritis	5.02e-05	0.000489	CcSEcCtD
Cyproterone acetate—Discomfort—Methylprednisolone—rheumatoid arthritis	5.01e-05	0.000488	CcSEcCtD
Cyproterone acetate—Headache—Azathioprine—rheumatoid arthritis	5e-05	0.000488	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	5e-05	0.000488	CcSEcCtD
Cyproterone acetate—Dizziness—Leflunomide—rheumatoid arthritis	4.99e-05	0.000486	CcSEcCtD
Cyproterone acetate—Constipation—Cyclosporine—rheumatoid arthritis	4.98e-05	0.000485	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—rheumatoid arthritis	4.96e-05	0.000483	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—rheumatoid arthritis	4.94e-05	0.00304	CbGpPWpGaD
Cyproterone acetate—Anorexia—Hydrocortisone—rheumatoid arthritis	4.93e-05	0.000481	CcSEcCtD
Cyproterone acetate—Angiopathy—Prednisone—rheumatoid arthritis	4.92e-05	0.000479	CcSEcCtD
Cyproterone acetate—Immune system disorder—Prednisone—rheumatoid arthritis	4.89e-05	0.000477	CcSEcCtD
Cyproterone acetate—Malaise—Betamethasone—rheumatoid arthritis	4.88e-05	0.000476	CcSEcCtD
Cyproterone acetate—Malaise—Dexamethasone—rheumatoid arthritis	4.88e-05	0.000476	CcSEcCtD
Cyproterone acetate—Oedema—Triamcinolone—rheumatoid arthritis	4.87e-05	0.000475	CcSEcCtD
Cyproterone acetate—Syncope—Betamethasone—rheumatoid arthritis	4.86e-05	0.000474	CcSEcCtD
Cyproterone acetate—Syncope—Dexamethasone—rheumatoid arthritis	4.86e-05	0.000474	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—rheumatoid arthritis	4.84e-05	0.000472	CcSEcCtD
Cyproterone acetate—Hypotension—Hydrocortisone—rheumatoid arthritis	4.83e-05	0.000471	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	4.83e-05	0.00298	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	4.83e-05	0.00298	CbGpPWpGaD
Cyproterone acetate—Haematuria—Methotrexate—rheumatoid arthritis	4.81e-05	0.000469	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MMP1—rheumatoid arthritis	4.8e-05	0.00296	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Cyclosporine—rheumatoid arthritis	4.8e-05	0.000468	CcSEcCtD
Cyproterone acetate—Vomiting—Leflunomide—rheumatoid arthritis	4.8e-05	0.000468	CcSEcCtD
Cyproterone acetate—Shock—Triamcinolone—rheumatoid arthritis	4.79e-05	0.000467	CcSEcCtD
Cyproterone acetate—Alopecia—Prednisone—rheumatoid arthritis	4.79e-05	0.000467	CcSEcCtD
Cyproterone acetate—Shock—Methylprednisolone—rheumatoid arthritis	4.78e-05	0.000466	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	4.77e-05	0.000465	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	4.77e-05	0.000465	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MAPK8—rheumatoid arthritis	4.76e-05	0.00293	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	4.76e-05	0.000464	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Dexamethasone—rheumatoid arthritis	4.76e-05	0.000464	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Betamethasone—rheumatoid arthritis	4.76e-05	0.000464	CcSEcCtD
Cyproterone acetate—Rash—Leflunomide—rheumatoid arthritis	4.76e-05	0.000464	CcSEcCtD
Cyproterone acetate—Tachycardia—Triamcinolone—rheumatoid arthritis	4.75e-05	0.000464	CcSEcCtD
Cyproterone acetate—Dermatitis—Leflunomide—rheumatoid arthritis	4.75e-05	0.000463	CcSEcCtD
Cyproterone acetate—Mental disorder—Prednisone—rheumatoid arthritis	4.75e-05	0.000463	CcSEcCtD
Cyproterone acetate—Nausea—Azathioprine—rheumatoid arthritis	4.74e-05	0.000463	CcSEcCtD
Cyproterone acetate—Tachycardia—Methylprednisolone—rheumatoid arthritis	4.74e-05	0.000463	CcSEcCtD
Cyproterone acetate—Headache—Leflunomide—rheumatoid arthritis	4.73e-05	0.000461	CcSEcCtD
Cyproterone acetate—Skin disorder—Methylprednisolone—rheumatoid arthritis	4.72e-05	0.00046	CcSEcCtD
Cyproterone acetate—Malnutrition—Prednisone—rheumatoid arthritis	4.72e-05	0.00046	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	4.71e-05	0.000459	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	4.7e-05	0.000458	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—rheumatoid arthritis	4.66e-05	0.00287	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—rheumatoid arthritis	4.64e-05	0.00286	CbGpPWpGaD
Cyproterone acetate—Urticaria—Cyclosporine—rheumatoid arthritis	4.62e-05	0.000451	CcSEcCtD
Cyproterone acetate—Abdominal pain—Cyclosporine—rheumatoid arthritis	4.6e-05	0.000449	CcSEcCtD
Cyproterone acetate—Body temperature increased—Cyclosporine—rheumatoid arthritis	4.6e-05	0.000449	CcSEcCtD
Cyproterone acetate—Discomfort—Betamethasone—rheumatoid arthritis	4.56e-05	0.000444	CcSEcCtD
Cyproterone acetate—Discomfort—Dexamethasone—rheumatoid arthritis	4.56e-05	0.000444	CcSEcCtD
Cyproterone acetate—Dyspepsia—Hydrocortisone—rheumatoid arthritis	4.55e-05	0.000444	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—rheumatoid arthritis	4.55e-05	0.000444	CcSEcCtD
Cyproterone acetate—Hypotension—Methylprednisolone—rheumatoid arthritis	4.54e-05	0.000443	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—rheumatoid arthritis	4.53e-05	0.000442	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—rheumatoid arthritis	4.53e-05	0.000442	CcSEcCtD
Cyproterone acetate—Decreased appetite—Hydrocortisone—rheumatoid arthritis	4.5e-05	0.000439	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	4.49e-05	0.00277	CbGpPWpGaD
Cyproterone acetate—Nausea—Leflunomide—rheumatoid arthritis	4.48e-05	0.000437	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	4.47e-05	0.000436	CcSEcCtD
Cyproterone acetate—Fatigue—Hydrocortisone—rheumatoid arthritis	4.46e-05	0.000435	CcSEcCtD
Cyproterone acetate—Oedema—Dexamethasone—rheumatoid arthritis	4.42e-05	0.000431	CcSEcCtD
Cyproterone acetate—Oedema—Betamethasone—rheumatoid arthritis	4.42e-05	0.000431	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisone—rheumatoid arthritis	4.38e-05	0.000427	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisolone—rheumatoid arthritis	4.37e-05	0.000426	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—rheumatoid arthritis	4.36e-05	0.000425	CcSEcCtD
Cyproterone acetate—Anaemia—Prednisone—rheumatoid arthritis	4.36e-05	0.000425	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	4.35e-05	0.00268	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—RBPJ—rheumatoid arthritis	4.35e-05	0.00268	CbGpPWpGaD
Cyproterone acetate—Shock—Betamethasone—rheumatoid arthritis	4.35e-05	0.000424	CcSEcCtD
Cyproterone acetate—Shock—Dexamethasone—rheumatoid arthritis	4.35e-05	0.000424	CcSEcCtD
Cyproterone acetate—Dyspnoea—Triamcinolone—rheumatoid arthritis	4.34e-05	0.000423	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CXCL8—rheumatoid arthritis	4.34e-05	0.00267	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Dexamethasone—rheumatoid arthritis	4.33e-05	0.000423	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Betamethasone—rheumatoid arthritis	4.33e-05	0.000423	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—rheumatoid arthritis	4.33e-05	0.000423	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—FAS—rheumatoid arthritis	4.33e-05	0.00267	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Betamethasone—rheumatoid arthritis	4.33e-05	0.000422	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	4.33e-05	0.000422	CcSEcCtD
Cyproterone acetate—Tachycardia—Betamethasone—rheumatoid arthritis	4.31e-05	0.000421	CcSEcCtD
Cyproterone acetate—Tachycardia—Dexamethasone—rheumatoid arthritis	4.31e-05	0.000421	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Cyclosporine—rheumatoid arthritis	4.29e-05	0.000418	CcSEcCtD
Cyproterone acetate—Dyspepsia—Triamcinolone—rheumatoid arthritis	4.29e-05	0.000418	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—rheumatoid arthritis	4.28e-05	0.000417	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methylprednisolone—rheumatoid arthritis	4.28e-05	0.000417	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	4.27e-05	0.000417	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Betamethasone—rheumatoid arthritis	4.27e-05	0.000417	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	4.26e-05	0.000416	CcSEcCtD
Cyproterone acetate—Malaise—Prednisone—rheumatoid arthritis	4.25e-05	0.000415	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—rheumatoid arthritis	4.23e-05	0.000413	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	4.23e-05	0.000413	CcSEcCtD
Cyproterone acetate—Syncope—Prednisone—rheumatoid arthritis	4.23e-05	0.000412	CcSEcCtD
Cyproterone acetate—Anorexia—Dexamethasone—rheumatoid arthritis	4.21e-05	0.000411	CcSEcCtD
Cyproterone acetate—Anorexia—Betamethasone—rheumatoid arthritis	4.21e-05	0.000411	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisolone—rheumatoid arthritis	4.21e-05	0.00041	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1A—rheumatoid arthritis	4.2e-05	0.00259	CbGpPWpGaD
Cyproterone acetate—Fatigue—Triamcinolone—rheumatoid arthritis	4.2e-05	0.00041	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	4.2e-05	0.00258	CbGpPWpGaD
Cyproterone acetate—Fatigue—Methylprednisolone—rheumatoid arthritis	4.19e-05	0.000409	CcSEcCtD
Cyproterone acetate—Asthenia—Cyclosporine—rheumatoid arthritis	4.18e-05	0.000407	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—rheumatoid arthritis	4.18e-05	0.00257	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Prednisone—rheumatoid arthritis	4.15e-05	0.000404	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—rheumatoid arthritis	4.14e-05	0.00255	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HNRNPA2B1—rheumatoid arthritis	4.14e-05	0.00255	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—rheumatoid arthritis	4.13e-05	0.00254	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MED1—rheumatoid arthritis	4.13e-05	0.00254	CbGpPWpGaD
Cyproterone acetate—Hypotension—Dexamethasone—rheumatoid arthritis	4.13e-05	0.000403	CcSEcCtD
Cyproterone acetate—Hypotension—Betamethasone—rheumatoid arthritis	4.13e-05	0.000403	CcSEcCtD
Cyproterone acetate—Pruritus—Cyclosporine—rheumatoid arthritis	4.12e-05	0.000402	CcSEcCtD
Cyproterone acetate—Urticaria—Hydrocortisone—rheumatoid arthritis	4.11e-05	0.000401	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—rheumatoid arthritis	4.11e-05	0.000401	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—rheumatoid arthritis	4.11e-05	0.00253	CbGpPWpGaD
Cyproterone acetate—Immune system disorder—Methotrexate—rheumatoid arthritis	4.09e-05	0.000399	CcSEcCtD
Cyproterone acetate—Abdominal pain—Hydrocortisone—rheumatoid arthritis	4.09e-05	0.000399	CcSEcCtD
Cyproterone acetate—Body temperature increased—Hydrocortisone—rheumatoid arthritis	4.09e-05	0.000399	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—rheumatoid arthritis	4.08e-05	0.000398	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—rheumatoid arthritis	4.06e-05	0.000396	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Triamcinolone—rheumatoid arthritis	4.01e-05	0.000391	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	4.01e-05	0.000391	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—rheumatoid arthritis	4e-05	0.00039	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	3.99e-05	0.000389	CcSEcCtD
Cyproterone acetate—Diarrhoea—Cyclosporine—rheumatoid arthritis	3.98e-05	0.000388	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—LEP—rheumatoid arthritis	3.98e-05	0.00245	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	3.97e-05	0.000388	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisone—rheumatoid arthritis	3.97e-05	0.000387	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—rheumatoid arthritis	3.97e-05	0.000387	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—rheumatoid arthritis	3.94e-05	0.000384	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	3.94e-05	0.00243	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—rheumatoid arthritis	3.92e-05	0.00241	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Prednisolone—rheumatoid arthritis	3.9e-05	0.000381	CcSEcCtD
Cyproterone acetate—Dyspepsia—Betamethasone—rheumatoid arthritis	3.89e-05	0.000379	CcSEcCtD
Cyproterone acetate—Dyspepsia—Dexamethasone—rheumatoid arthritis	3.89e-05	0.000379	CcSEcCtD
Cyproterone acetate—Urticaria—Triamcinolone—rheumatoid arthritis	3.87e-05	0.000377	CcSEcCtD
Cyproterone acetate—Urticaria—Methylprednisolone—rheumatoid arthritis	3.86e-05	0.000377	CcSEcCtD
Cyproterone acetate—Body temperature increased—Triamcinolone—rheumatoid arthritis	3.85e-05	0.000376	CcSEcCtD
Cyproterone acetate—Dizziness—Cyclosporine—rheumatoid arthritis	3.85e-05	0.000375	CcSEcCtD
Cyproterone acetate—Oedema—Prednisone—rheumatoid arthritis	3.85e-05	0.000375	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methylprednisolone—rheumatoid arthritis	3.84e-05	0.000375	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dexamethasone—rheumatoid arthritis	3.84e-05	0.000375	CcSEcCtD
Cyproterone acetate—Decreased appetite—Betamethasone—rheumatoid arthritis	3.84e-05	0.000375	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—rheumatoid arthritis	3.82e-05	0.00235	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	3.82e-05	0.000372	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	3.82e-05	0.000372	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	3.81e-05	0.000372	CcSEcCtD
Cyproterone acetate—Fatigue—Betamethasone—rheumatoid arthritis	3.81e-05	0.000372	CcSEcCtD
Cyproterone acetate—Fatigue—Dexamethasone—rheumatoid arthritis	3.81e-05	0.000372	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6R—rheumatoid arthritis	3.8e-05	0.00234	CbGpPWpGaD
Cyproterone acetate—Shock—Prednisone—rheumatoid arthritis	3.79e-05	0.000369	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—DDX6—rheumatoid arthritis	3.78e-05	0.00233	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Prednisone—rheumatoid arthritis	3.78e-05	0.000368	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisone—rheumatoid arthritis	3.76e-05	0.000366	CcSEcCtD
Cyproterone acetate—Skin disorder—Prednisone—rheumatoid arthritis	3.74e-05	0.000365	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6ST—rheumatoid arthritis	3.73e-05	0.0023	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Prednisone—rheumatoid arthritis	3.72e-05	0.000363	CcSEcCtD
Cyproterone acetate—Asthenia—Hydrocortisone—rheumatoid arthritis	3.71e-05	0.000362	CcSEcCtD
Cyproterone acetate—Vomiting—Cyclosporine—rheumatoid arthritis	3.7e-05	0.000361	CcSEcCtD
Cyproterone acetate—Rash—Cyclosporine—rheumatoid arthritis	3.67e-05	0.000358	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—rheumatoid arthritis	3.67e-05	0.000358	CcSEcCtD
Cyproterone acetate—Dermatitis—Cyclosporine—rheumatoid arthritis	3.67e-05	0.000358	CcSEcCtD
Cyproterone acetate—Pruritus—Hydrocortisone—rheumatoid arthritis	3.66e-05	0.000357	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—rheumatoid arthritis	3.66e-05	0.000357	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—FADS2—rheumatoid arthritis	3.65e-05	0.00225	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—rheumatoid arthritis	3.65e-05	0.00225	CbGpPWpGaD
Cyproterone acetate—Headache—Cyclosporine—rheumatoid arthritis	3.65e-05	0.000356	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—rheumatoid arthritis	3.64e-05	0.000355	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dexamethasone—rheumatoid arthritis	3.64e-05	0.000355	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Betamethasone—rheumatoid arthritis	3.64e-05	0.000355	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	3.61e-05	0.000352	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	3.61e-05	0.000352	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Triamcinolone—rheumatoid arthritis	3.59e-05	0.00035	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	3.58e-05	0.000349	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—rheumatoid arthritis	3.55e-05	0.000347	CcSEcCtD
Cyproterone acetate—Diarrhoea—Hydrocortisone—rheumatoid arthritis	3.54e-05	0.000345	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—rheumatoid arthritis	3.53e-05	0.000344	CcSEcCtD
Cyproterone acetate—Urticaria—Dexamethasone—rheumatoid arthritis	3.51e-05	0.000342	CcSEcCtD
Cyproterone acetate—Urticaria—Betamethasone—rheumatoid arthritis	3.51e-05	0.000342	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisolone—rheumatoid arthritis	3.5e-05	0.000342	CcSEcCtD
Cyproterone acetate—Asthenia—Triamcinolone—rheumatoid arthritis	3.5e-05	0.000341	CcSEcCtD
Cyproterone acetate—Body temperature increased—Betamethasone—rheumatoid arthritis	3.49e-05	0.000341	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dexamethasone—rheumatoid arthritis	3.49e-05	0.000341	CcSEcCtD
Cyproterone acetate—Abdominal pain—Betamethasone—rheumatoid arthritis	3.49e-05	0.000341	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dexamethasone—rheumatoid arthritis	3.49e-05	0.000341	CcSEcCtD
Cyproterone acetate—Asthenia—Methylprednisolone—rheumatoid arthritis	3.49e-05	0.00034	CcSEcCtD
Cyproterone acetate—Nausea—Cyclosporine—rheumatoid arthritis	3.46e-05	0.000337	CcSEcCtD
Cyproterone acetate—Pruritus—Triamcinolone—rheumatoid arthritis	3.45e-05	0.000336	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—rheumatoid arthritis	3.44e-05	0.000335	CcSEcCtD
Cyproterone acetate—Pruritus—Methylprednisolone—rheumatoid arthritis	3.44e-05	0.000335	CcSEcCtD
Cyproterone acetate—Dizziness—Hydrocortisone—rheumatoid arthritis	3.42e-05	0.000334	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—rheumatoid arthritis	3.42e-05	0.0021	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Prednisone—rheumatoid arthritis	3.39e-05	0.00033	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—rheumatoid arthritis	3.36e-05	0.00207	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Prednisone—rheumatoid arthritis	3.35e-05	0.000326	CcSEcCtD
Cyproterone acetate—Rash—Prednisolone—rheumatoid arthritis	3.34e-05	0.000326	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisolone—rheumatoid arthritis	3.34e-05	0.000325	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	3.33e-05	0.000325	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methylprednisolone—rheumatoid arthritis	3.33e-05	0.000324	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—rheumatoid arthritis	3.32e-05	0.000324	CcSEcCtD
Cyproterone acetate—Headache—Prednisolone—rheumatoid arthritis	3.32e-05	0.000324	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—rheumatoid arthritis	3.32e-05	0.000323	CcSEcCtD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—rheumatoid arthritis	3.31e-05	0.00204	CbGpPWpGaD
Cyproterone acetate—Constipation—Prednisone—rheumatoid arthritis	3.29e-05	0.000321	CcSEcCtD
Cyproterone acetate—Vomiting—Hydrocortisone—rheumatoid arthritis	3.29e-05	0.000321	CcSEcCtD
Cyproterone acetate—Rash—Hydrocortisone—rheumatoid arthritis	3.26e-05	0.000318	CcSEcCtD
Cyproterone acetate—Dermatitis—Hydrocortisone—rheumatoid arthritis	3.26e-05	0.000318	CcSEcCtD
Cyproterone acetate—Headache—Hydrocortisone—rheumatoid arthritis	3.24e-05	0.000316	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—rheumatoid arthritis	3.23e-05	0.00199	CbGpPWpGaD
Cyproterone acetate—Dizziness—Triamcinolone—rheumatoid arthritis	3.22e-05	0.000314	CcSEcCtD
Cyproterone acetate—Dizziness—Methylprednisolone—rheumatoid arthritis	3.21e-05	0.000313	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisone—rheumatoid arthritis	3.17e-05	0.000309	CcSEcCtD
Cyproterone acetate—Asthenia—Dexamethasone—rheumatoid arthritis	3.17e-05	0.000309	CcSEcCtD
Cyproterone acetate—Asthenia—Betamethasone—rheumatoid arthritis	3.17e-05	0.000309	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—rheumatoid arthritis	3.15e-05	0.000308	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—rheumatoid arthritis	3.15e-05	0.000307	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—rheumatoid arthritis	3.15e-05	0.000307	CcSEcCtD
Cyproterone acetate—Nausea—Prednisolone—rheumatoid arthritis	3.15e-05	0.000307	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—HNRNPA2B1—rheumatoid arthritis	3.14e-05	0.00193	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ZFP36—rheumatoid arthritis	3.14e-05	0.00193	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—UBE2D1—rheumatoid arthritis	3.13e-05	0.00193	CbGpPWpGaD
Cyproterone acetate—Pruritus—Betamethasone—rheumatoid arthritis	3.13e-05	0.000305	CcSEcCtD
Cyproterone acetate—Pruritus—Dexamethasone—rheumatoid arthritis	3.13e-05	0.000305	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—rheumatoid arthritis	3.12e-05	0.000305	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—rheumatoid arthritis	3.11e-05	0.000303	CcSEcCtD
Cyproterone acetate—Vomiting—Triamcinolone—rheumatoid arthritis	3.1e-05	0.000302	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—rheumatoid arthritis	3.1e-05	0.00191	CbGpPWpGaD
Cyproterone acetate—Vomiting—Methylprednisolone—rheumatoid arthritis	3.09e-05	0.000301	CcSEcCtD
Cyproterone acetate—Nausea—Hydrocortisone—rheumatoid arthritis	3.07e-05	0.0003	CcSEcCtD
Cyproterone acetate—Rash—Triamcinolone—rheumatoid arthritis	3.07e-05	0.000299	CcSEcCtD
Cyproterone acetate—Dermatitis—Triamcinolone—rheumatoid arthritis	3.07e-05	0.000299	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—rheumatoid arthritis	3.07e-05	0.000299	CcSEcCtD
Cyproterone acetate—Rash—Methylprednisolone—rheumatoid arthritis	3.06e-05	0.000299	CcSEcCtD
Cyproterone acetate—Dermatitis—Methylprednisolone—rheumatoid arthritis	3.06e-05	0.000299	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—rheumatoid arthritis	3.06e-05	0.000298	CcSEcCtD
Cyproterone acetate—Headache—Triamcinolone—rheumatoid arthritis	3.05e-05	0.000298	CcSEcCtD
Cyproterone acetate—Headache—Methylprednisolone—rheumatoid arthritis	3.05e-05	0.000297	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—rheumatoid arthritis	3.04e-05	0.000297	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—rheumatoid arthritis	3.04e-05	0.000297	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	3.04e-05	0.00187	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Dexamethasone—rheumatoid arthritis	3.02e-05	0.000295	CcSEcCtD
Cyproterone acetate—Diarrhoea—Betamethasone—rheumatoid arthritis	3.02e-05	0.000295	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	3.01e-05	0.00185	CbGpPWpGaD
Cyproterone acetate—Hypotension—Methotrexate—rheumatoid arthritis	3.01e-05	0.000293	CcSEcCtD
Cyproterone acetate—Dizziness—Dexamethasone—rheumatoid arthritis	2.92e-05	0.000285	CcSEcCtD
Cyproterone acetate—Dizziness—Betamethasone—rheumatoid arthritis	2.92e-05	0.000285	CcSEcCtD
Cyproterone acetate—Nausea—Triamcinolone—rheumatoid arthritis	2.89e-05	0.000282	CcSEcCtD
Cyproterone acetate—Nausea—Methylprednisolone—rheumatoid arthritis	2.89e-05	0.000282	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	2.89e-05	0.00178	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6R—rheumatoid arthritis	2.88e-05	0.00177	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—DDX6—rheumatoid arthritis	2.87e-05	0.00177	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Methotrexate—rheumatoid arthritis	2.87e-05	0.00028	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisone—rheumatoid arthritis	2.84e-05	0.000277	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—rheumatoid arthritis	2.83e-05	0.000276	CcSEcCtD
Cyproterone acetate—Vomiting—Betamethasone—rheumatoid arthritis	2.81e-05	0.000274	CcSEcCtD
Cyproterone acetate—Vomiting—Dexamethasone—rheumatoid arthritis	2.81e-05	0.000274	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—rheumatoid arthritis	2.8e-05	0.000273	CcSEcCtD
Cyproterone acetate—Rash—Dexamethasone—rheumatoid arthritis	2.79e-05	0.000272	CcSEcCtD
Cyproterone acetate—Rash—Betamethasone—rheumatoid arthritis	2.79e-05	0.000272	CcSEcCtD
Cyproterone acetate—Dermatitis—Dexamethasone—rheumatoid arthritis	2.78e-05	0.000272	CcSEcCtD
Cyproterone acetate—Dermatitis—Betamethasone—rheumatoid arthritis	2.78e-05	0.000272	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.78e-05	0.000271	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—rheumatoid arthritis	2.77e-05	0.00027	CcSEcCtD
Cyproterone acetate—Headache—Dexamethasone—rheumatoid arthritis	2.77e-05	0.00027	CcSEcCtD
Cyproterone acetate—Headache—Betamethasone—rheumatoid arthritis	2.77e-05	0.00027	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—NFKB1—rheumatoid arthritis	2.76e-05	0.0017	CbGpPWpGaD
Cyproterone acetate—Asthenia—Prednisone—rheumatoid arthritis	2.76e-05	0.000269	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—RBPJ—rheumatoid arthritis	2.76e-05	0.0017	CbGpPWpGaD
Cyproterone acetate—Pruritus—Prednisone—rheumatoid arthritis	2.72e-05	0.000266	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	2.69e-05	0.00166	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—TNFSF13—rheumatoid arthritis	2.67e-05	0.00164	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—rheumatoid arthritis	2.66e-05	0.00164	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Methotrexate—rheumatoid arthritis	2.65e-05	0.000258	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	2.64e-05	0.00162	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Prednisone—rheumatoid arthritis	2.63e-05	0.000257	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	2.63e-05	0.000257	CcSEcCtD
Cyproterone acetate—Nausea—Dexamethasone—rheumatoid arthritis	2.63e-05	0.000256	CcSEcCtD
Cyproterone acetate—Nausea—Betamethasone—rheumatoid arthritis	2.63e-05	0.000256	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—MED1—rheumatoid arthritis	2.62e-05	0.00161	CbGpPWpGaD
Cyproterone acetate—Urticaria—Methotrexate—rheumatoid arthritis	2.56e-05	0.000249	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—rheumatoid arthritis	2.55e-05	0.000248	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—rheumatoid arthritis	2.54e-05	0.000248	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—rheumatoid arthritis	2.54e-05	0.000248	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—rheumatoid arthritis	2.51e-05	0.00154	CbGpPWpGaD
Cyproterone acetate—Vomiting—Prednisone—rheumatoid arthritis	2.45e-05	0.000239	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	2.44e-05	0.0015	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLD4—rheumatoid arthritis	2.44e-05	0.0015	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—rheumatoid arthritis	2.44e-05	0.0015	CbGpPWpGaD
Cyproterone acetate—Rash—Prednisone—rheumatoid arthritis	2.43e-05	0.000237	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—rheumatoid arthritis	2.42e-05	0.000236	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—rheumatoid arthritis	2.41e-05	0.000235	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—rheumatoid arthritis	2.39e-05	0.00147	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ZFP36—rheumatoid arthritis	2.38e-05	0.00146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—rheumatoid arthritis	2.38e-05	0.00146	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—UBE2D1—rheumatoid arthritis	2.37e-05	0.00146	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Methotrexate—rheumatoid arthritis	2.37e-05	0.000231	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ACAN—rheumatoid arthritis	2.35e-05	0.00145	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—rheumatoid arthritis	2.34e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—rheumatoid arthritis	2.31e-05	0.000225	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	2.29e-05	0.00141	CbGpPWpGaD
Cyproterone acetate—Nausea—Prednisone—rheumatoid arthritis	2.29e-05	0.000223	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	2.28e-05	0.00141	CbGpPWpGaD
Cyproterone acetate—Pruritus—Methotrexate—rheumatoid arthritis	2.28e-05	0.000222	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	2.25e-05	0.00139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC25A12—rheumatoid arthritis	2.21e-05	0.00136	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Methotrexate—rheumatoid arthritis	2.2e-05	0.000215	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	2.19e-05	0.00135	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—rheumatoid arthritis	2.16e-05	0.00133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGES—rheumatoid arthritis	2.15e-05	0.00133	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GC—rheumatoid arthritis	2.15e-05	0.00133	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—rheumatoid arthritis	2.15e-05	0.00132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—rheumatoid arthritis	2.15e-05	0.00132	CbGpPWpGaD
Cyproterone acetate—Dizziness—Methotrexate—rheumatoid arthritis	2.13e-05	0.000207	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	2.09e-05	0.00129	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RBPJ—rheumatoid arthritis	2.09e-05	0.00129	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	2.08e-05	0.00128	CbGpPWpGaD
Cyproterone acetate—Vomiting—Methotrexate—rheumatoid arthritis	2.05e-05	0.000199	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	2.04e-05	0.00126	CbGpPWpGaD
Cyproterone acetate—Rash—Methotrexate—rheumatoid arthritis	2.03e-05	0.000198	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—rheumatoid arthritis	2.03e-05	0.000198	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—TNFSF13—rheumatoid arthritis	2.02e-05	0.00125	CbGpPWpGaD
Cyproterone acetate—Headache—Methotrexate—rheumatoid arthritis	2.02e-05	0.000197	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PLB1—rheumatoid arthritis	2e-05	0.00123	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MED1—rheumatoid arthritis	1.99e-05	0.00123	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—rheumatoid arthritis	1.97e-05	0.00121	CbGpPWpGaD
Cyproterone acetate—Nausea—Methotrexate—rheumatoid arthritis	1.91e-05	0.000186	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.91e-05	0.00117	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—rheumatoid arthritis	1.9e-05	0.00117	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	1.85e-05	0.00114	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—rheumatoid arthritis	1.84e-05	0.00113	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—rheumatoid arthritis	1.81e-05	0.00112	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.78e-05	0.0011	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MED1—rheumatoid arthritis	1.76e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	1.69e-05	0.00104	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—B3GNT2—rheumatoid arthritis	1.63e-05	0.001	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACP5—rheumatoid arthritis	1.63e-05	0.001	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—rheumatoid arthritis	1.63e-05	0.001	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—rheumatoid arthritis	1.59e-05	0.000979	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	1.57e-05	0.000967	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—UBE2D1—rheumatoid arthritis	1.51e-05	0.000927	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—rheumatoid arthritis	1.48e-05	0.000914	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BGN—rheumatoid arthritis	1.47e-05	0.000904	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALOX5—rheumatoid arthritis	1.35e-05	0.000832	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	1.28e-05	0.00079	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.19e-05	0.000732	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—rheumatoid arthritis	1.15e-05	0.000709	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—UBE2D1—rheumatoid arthritis	1.14e-05	0.000704	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO1—rheumatoid arthritis	1.1e-05	0.000678	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.08e-05	0.000667	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—rheumatoid arthritis	1.04e-05	0.000638	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	9.48e-06	0.000584	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—rheumatoid arthritis	8.73e-06	0.000538	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAT—rheumatoid arthritis	7.93e-06	0.000488	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—rheumatoid arthritis	6.62e-06	0.000408	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—rheumatoid arthritis	5.3e-06	0.000326	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—rheumatoid arthritis	4.83e-06	0.000297	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—rheumatoid arthritis	4.62e-06	0.000284	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—rheumatoid arthritis	4.22e-06	0.00026	CbGpPWpGaD
